CDIO - Cardio Diagnostics Holdings Inc
4.86
-0.440 -9.053%
Share volume: 569,150
Last Updated: 03-09-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$5.30
-0.44
-0.08%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-12-2024 | 11-13-2024 | 03-20-2025 | 05-15-2025 | 11-12-2025 | |
| Total revenue | 15.928 K | 7.870 K | 6.580 K | 4.512 K | 940.000 | 2.855 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 15.928 K | 7.870 K | 6.580 K | 4.512 K | 940.000 | 2.855 K | |
| -50.59% | -16.39% | -31.43% | -79.17% | 203.72% | |||
| Operating expenses | 4.135 M | 1.228 M | 1.359 M | 1.477 M | 1.544 M | 1.714 M | |
| Selling general and admin | 4.124 M | 1.220 M | 1.353 M | 1.472 M | 1.542 M | 1.714 M | |
| Research and development | 10.840 K | 7.280 K | 5.247 K | 5.758 K | 2.200 K | 0.000 | |
| Total expenses | 4.174 M | 1.290 M | 1.416 M | 1.521 M | 1.632 M | 1.714 M | |
| -69.09% | 9.70% | 7.44% | 7.27% | 5.08% | |||
| Operating income | -4.158 M | -1.282 M | -1.409 M | -1.516 M | -1.631 M | -1.712 M | |
| Ebit | -4.164 M | -1.288 M | -1.409 M | -1.505 M | -1.635 M | -1.715 M | |
| Pretax income | -4.164 M | -1.288 M | -1.413 M | -1.519 M | -1.635 M | -1.715 M | |
| -69.07% | 9.67% | 7.56% | 7.62% | 4.86% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -4.164 M | -1.288 M | -1.413 M | -1.519 M | -1.635 M | -1.715 M | |
| 69.07% | -9.67% | -7.56% | -7.62% | -4.86% |